Filing Flows › Gilead Sciences (GILD) › Net income
Gilead Sciences (GILD) net income by quarter
Gilead Sciences' net income was $2.4B in Q3 2026 (third quarter 2026), +20% from Q1 2026. Over the last 6 quarters it ranged from $1.3B (Q1 2025) to $3.1B (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.4B | +20% | -20% |
| Q1 2026 | $2.0B | -7% | +54% |
| Q4 2025 | $2.2B | -28% | — |
| Q3 2025 | $3.1B | +56% | — |
| Q2 2025 | $2.0B | +49% | — |
| Q1 2025 | $1.3B | — | — |
Q3 2026 at a glance
Gilead Sciences, Q3 2026: revenue $8.3B (+7% year over year), operating margin 41.7%, net earnings $2.4B, operating cash flow $5.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Gilead Sciences' net income?
Gilead Sciences' net income was $2.4B in Q3 2026 (third quarter 2026), +20% from Q1 2026.
How has Gilead Sciences' net income changed?
Over the last 6 quarters it ranged from $1.3B (Q1 2025) to $3.1B (Q3 2025).